Sanofi and Boehringer in OTC asset swap talks

15 December 2015 - Deborah Wilkes

Archived

Sanofi and Boehringer Ingelheim have entered into exclusive negotiations on a business swap that would see Sanofi become a global leader in consumer healthcare and Boehringer Ingelheim become the second-largest animal health company. The two companies aim to close the potential transaction in the fourth quarter of 2016.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: